Xalkori, also known as crizotinib, is a medication used in the treatment of certain types of cancer, specifically non-small cell lung cancer (NSCLC) and anaplastic lymphoma kinase (ALK)-positive metastatic NSCLC. This drug belongs to a class of medications called kinase inhibitors, which work by blocking the action of abnormal proteins that promote the growth of cancer cells.

Xalkori has shown promising results in clinical trials, with many patients experiencing significant tumor shrinkage and prolonged periods of disease control. It is typically prescribed for patients whose cancer has spread or cannot be surgically removed, and who have tested positive for the ALK gene mutation.

As with any medication, Xalkori does come with potential side effects. Common side effects may include nausea, diarrhea, fatigue, and vision problems. It is important to discuss any concerns or side effects with your healthcare provider, as they may be able to provide guidance or adjust your treatment plan accordingly.

It is crucial to take Xalkori exactly as prescribed by your healthcare provider, as missing doses or stopping treatment prematurely can affect its effectiveness. Your healthcare provider will monitor your progress closely and may adjust your dosage or schedule as needed.

Overall, Xalkori has shown to be an effective treatment option for patients with certain types of cancer, offering hope and improved outcomes for many individuals. If you have been prescribed Xalkori, it is important to follow your healthcare provider’s instructions and communicate any concerns or questions you may have throughout your treatment journey.